George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHon Hai Precsn Regulatory News (HHPD)

Share Price Information for Hon Hai Precsn (HHPD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.46
Bid: 9.43
Ask: 9.46
Change: 0.22 (2.38%)
Spread: 0.03 (0.318%)
Open: 9.50
High: 9.50
Low: 9.43
Prev. Close: 9.24
HHPD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2020 3rd Quarter Results

13 Nov 2020 09:17

RNS Number : 2577F
Hon Hai Precision Industry Co Ld
13 November 2020
 

HON HAI PRECISION INDUSTRY CO., LTD. AND SUBSIDIARIES CONSOLIDATED SHEETS

2020 3rd IFRSs Consolidated Financial Statements

 

Unit: NT$ thousand

Balance Sheet

Code

Accounting Title

2020/9/30

2019/12/31

2019/9/30

Assets

 Current assets

1100

Cash and cash equivalents

1,018,518,545

857,864,362

788,552,993

1110

Current financial assets at fair value through profit or loss

2,283,769

2,952,049

2,687,789

1136

Current financial assets at amortised cost

56,982,365

52,954,877

80,674,247

1170

Accounts receivable, net

674,576,103

987,278,438

973,106,359

1180

Accounts receivable due from related parties, net

42,466,691

44,754,604

52,969,656

1200

Other receivables

66,239,294

67,854,299

71,788,948

1210

Other receivables due from related parties

7,020,715

24,366,543

29,532,400

130X

Current inventories

707,992,299

515,772,177

690,816,511

1410

Prepayments

20,411,757

19,895,574

19,866,243

11XX

Total current assets

2,596,491,538

2,573,692,923

2,709,995,146

 Non-current assets

1510

Non-current financial assets at fair value through profit or loss

89,046,993

82,660,725

80,915,973

1517

Non-current financial assets at fair value through other comprehensive income

65,025,269

68,807,217

66,888,731

1535

Non-current financial assets at amortised cost

19,190,490

12,528,569

14,172,490

1550

Investments accounted for using equity method

164,428,944

168,631,642

170,025,603

1600

Property, plant and equipment

278,138,570

287,523,253

272,040,082

1755

Right-of-use assets

45,359,435

46,760,340

41,020,423

1760

Investment property, net

10,111,512

4,419,912

4,591,843

1780

Intangible assets

39,175,542

41,380,353

29,963,422

1840

Deferred tax assets

23,088,696

18,701,465

16,671,351

1900

Other non-current assets

14,041,943

15,835,299

8,796,992

15XX

Total non-current assets

747,607,394

747,248,775

705,086,910

1XXX

 Total assets

3,344,098,932

3,320,941,698

3,415,082,056

Liabilities and equity

 Liabilities

Current liabilities

2100

Current borrowings

435,373,222

380,866,050

427,896,910

2110

Short-term notes and bills payable

53,336,806

30,528,296

33,715,348

2120

Current financial liabilities at fair value through profit or loss

1,405,078

1,881,685

1,831,892

2170

Accounts payable

856,816,144

870,678,994

975,435,641

2180

Accounts payable to related parties

28,856,701

35,509,127

43,124,578

2200

Other payables

207,025,813

217,732,729

213,699,184

2230

Current tax liabilities

18,512,527

18,531,289

22,700,301

2250

Current provisions

2,632,722

2,725,293

2,546,871

2280

Current lease liabilities

8,244,367

7,131,038

5,979,730

2300

Other current liabilities

124,804,098

91,876,860

69,554,887

21XX

Total current liabilities

1,737,007,478

1,657,461,361

1,796,485,342

Non-current liabilities

2500

Non-current financial liabilities at fair value through profit or loss

1,650

0

6,300

2530

Bonds payable

158,033,607

175,505,344

181,220,286

2540

Non-current portion of non-current borrowings

27,075,056

41,576,252

52,463,172

2550

Non-current provisions

384,614

369,953

0

2570

Deferred tax liabilities

20,651,693

18,261,509

20,205,461

2580

Non-current lease liabilities

19,820,124

20,875,343

16,551,314

2600

Other non-current liabilities

9,408,965

7,266,519

7,051,102

25XX

Total non-current liabilities

235,375,709

263,854,920

277,497,635

2XXX

Total liabilities

1,972,383,187

1,921,316,281

2,073,982,977

 Equity

Equity attributable to owners of parent

Share capital

3110

Ordinary share

138,629,906

138,629,906

138,629,906

3100

Total Share Capital

138,629,906

138,629,906

138,629,906

Capital surplus

3210

Capital surplus, additional paid-in capital

88,501,031

88,501,031

88,501,031

3230

Capital surplus, difference between consideration and carrying amount of subsidiaries acquired or disposed

0

0

0

3235

Capital Surplus, changes in ownership interests in subsidiaries

102,598,404

99,189,558

94,147,189

3250

Capital surplus, donated assets received

0

0

0

3260

Capital surplus, changes in equity of associates and joint ventures accounted for using equity method

10,092,638

10,593,529

10,944,906

3271

Capital surplus, employee share options

0

0

0

3272

Capital surplus, share options

1,099,253

1,099,253

1,099,253

3273

Capital Surplus, restricted stock

0

0

0

3280

Capital surplus, others

0

0

0

3200

Total capital surplus

202,291,326

199,383,371

194,692,379

Retained earnings

3310

Legal reserve

161,043,748

149,512,874

149,512,874

3320

Special reserve

102,451,720

60,309,927

60,309,927

3350

Unappropriated retained earnings (accumulated deficit)

734,359,887

794,615,182

745,389,080

3300

Total retained earnings

997,855,355

1,004,437,983

955,211,881

Other equity interest

3410

Exchange differences on translation of foreign financial statements

(139,388,384)

(113,889,466)

(86,080,108)

3420

Unrealised gains (losses) from financial assets measured at fair value through other comprehensive income

11,511,403

11,437,746

4,246,979

3400

Total other equity interest

(127,876,981)

(102,451,720)

(81,833,129)

3500

Treasury shares

(15,194)

(15,194)

(15,194)

31XX

Total equity attributable to owners of parent

1,210,884,412

1,239,984,346

1,206,685,843

36XX

Non-controlling interests

160,831,333

159,641,071

134,413,236

3XXX

Total equity

1,371,715,745

1,399,625,417

1,341,099,079

3X2X

 Total liabilities and equity

3,344,098,932

3,320,941,698

3,415,082,056

3997

 Number of share capital awaiting retirement

0

0

0

3998

 Equivalent issue shares of advance receipts for ordinary share

0

0

0

3999

 Number of shares in entity held by entity and by its subsidiaries

1,483,078

1,483,078

1,483,078

 

Unit: NT$ thousands EPS Unit: NT$

Statement of Comprehensive Income

Code

Accounting Title

2020/7/1To9/30

2019/7/1To9/30

2020/1/1To9/30

2019/1/1To9/30

Operating revenue

4000

 Total operating revenue

1,291,541,100

1,387,792,029

3,349,011,129

3,601,878,654

Operating costs

5000

 Total operating costs

1,211,442,464

1,304,409,807

3,160,467,869

3,398,587,556

5900

Gross profit (loss) from operations

80,098,636

83,382,222

188,543,260

203,291,098

5950

Gross profit (loss) from operations

80,098,636

83,382,222

188,543,260

203,291,098

Operating expenses

6100

 Selling expenses

6,820,449

7,966,593

17,641,612

22,429,221

6200

 Administrative expenses

17,188,699

19,742,626

49,268,216

56,111,172

6300

 Research and development expenses

23,711,465

22,181,549

62,261,638

59,601,589

6000

 Total operating expenses

47,720,613

49,890,768

129,171,466

138,141,982

6900

Net operating income (loss)

32,378,023

33,491,454

59,371,794

65,149,116

Non-operating income and expenses

 Interest income

7100

Total interest income

10,287,767

18,854,647

37,907,112

54,860,653

 Other income

7010

Total other income

5,070,313

7,823,821

8,636,095

12,049,796

 Other gains and losses

7020

Other gains and losses, net

776,131

(6,095,326)

5,913,511

2,119,902

 Finance costs

7050

Finance costs, net

9,308,328

16,680,840

32,565,233

47,313,254

 Share of profit (loss) of associates and joint ventures accounted for using equity method

7060

Share of profit (loss) of associates and joint ventures accounted for using equity method, net

3,721,084

4,663,655

4,428,030

14,227,828

7000

 Total non-operating income and expenses

10,546,967

8,565,957

24,319,515

35,944,925

7900

Profit (loss) from continuing operations before tax

42,924,990

42,057,411

83,691,309

101,094,041

Tax expense (income)

7950

 Total tax expense (income)

8,683,341

8,239,655

21,901,183

25,085,478

8000

Profit (loss) from continuing operations

34,241,649

33,817,756

61,790,126

76,008,563

8200

Profit (loss)

34,241,649

33,817,756

61,790,126

76,008,563

Other comprehensive income

 Components of other comprehensive income that will not be reclassified to profit or loss

8316

Unrealised gains (losses) from investments in equity instruments measured at fair value through other comprehensive income

(3,303,339)

(3,382,569)

(2,610,510)

(717,439)

8320

Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will not be reclassified to profit or loss

957,828

190,889

(2,600,380)

489,908

8310

Components of other comprehensive income that will not be reclassified to profit or loss

(2,345,511)

(3,191,680)

(5,210,890)

(227,531)

 Components of other comprehensive income that will be reclassified to profit or loss

8361

Exchange differences on translation

11,607,802

(38,361,969)

(26,905,249)

(23,823,291)

8370

Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will be reclassified to profit or loss

1,614,384

(2,035,279)

(272,785)

553,746

8360

Components of other comprehensive income that will be reclassified to profit or loss

13,222,186

(40,397,248)

(27,178,034)

(23,269,545)

8300

 Total other comprehensive income

10,876,675

(43,588,928)

(32,388,924)

(23,497,076)

8500

Total comprehensive income

45,118,324

(9,771,172)

29,401,202

52,511,487

Profit (loss), attributable to:

8610

 Profit (loss), attributable to owners of parent

30,854,592

30,664,317

55,818,855

67,542,884

8620

 Profit (loss), attributable to non-controlling interests

3,387,057

3,153,439

5,971,271

8,465,679

Comprehensive income attributable to:

8710

 Comprehensive income, attributable to owners of parent

40,701,498

(9,584,987)

26,223,229

46,117,730

8720

 Comprehensive income, attributable to non-controlling interests

4,416,826

(186,185)

3,177,973

6,393,757

Basic earnings per share

9710

 Basic earnings (loss) per share from continuing operations

2.23

2.21

4.03

4.87

9750

 Total basic earnings per share

2.23

2.21

4.03

4.87

Diluted earnings per share

9810

 Diluted earnings (loss) per share from continuing operations

2.21

2.19

4.00

4.83

9850

 Total diluted earnings per share

2.21

2.19

4.00

4.83

 

Unit: NT$ thousands

Statements of Cash Flows

 

Code

Accounting Title

2020/1/1To9/30

2019/1/1To9/30

Cash flows from (used in) operating activities, indirect method

A00010

 Profit (loss) from continuing operations before tax

83,691,309

101,094,041

A10000

 Profit (loss) before tax

83,691,309

101,094,041

 Adjustments

Adjustments to reconcile profit (loss)

A20100

Depreciation expense

44,888,883

47,838,884

A20200

Amortization expense

3,162,402

1,208,492

A20300

Expected credit loss (gain) / Provision (reversal of provision) for bad debt expense

1,982,168

967,176

A20400

Net loss (gain) on financial assets or liabilities at fair value through profit or loss

(4,476,380)

(5,282,788)

A20900

Interest expense

32,023,775

46,984,815

A21200

Interest income

(37,907,112)

(54,860,653)

A21300

Dividend income

(3,396,328)

(5,486,503)

A22300

Share of loss (profit) of associates and joint ventures accounted for using equity method

(4,428,030)

(14,227,828)

A22500

Loss (gain) on disposal of property, plan and equipment

339,891

467,545

A23100

Loss (gain) on disposal of investments

(363,614)

78,074

A23500

Impairment loss on financial assets

0

157,082

A23700

Impairment loss on non-financial assets

0

138,896

A20010

Total adjustments to reconcile profit (loss)

31,825,655

17,983,192

Changes in operating assets and liabilities

Changes in operating assets

A31115

Decrease (increase) in financial assets at fair value through profit or loss, mandatorily measured at fair value

5,712,365

9,521,007

A31130

Decrease (increase) in notes receivable

(87,046)

375,898

A31150

Decrease (increase) in accounts receivable

311,128,001

34,947,002

A31160

Decrease (increase) in accounts receivable due from related parties

3,735,107

(4,798,827)

A31180

Decrease (increase) in other receivable

(9,408,360)

1,495,851

A31200

Adjustments for decrease (increase) in inventories

(192,220,122)

(64,940,236)

A31230

Decrease (increase) in prepayments

(516,183)

(269,983)

A31000

Total changes in operating assets

118,343,762

(23,669,288)

Changes in operating liabilities

A32125

Increase (decrease) in contract liabilities

4,343,987

1,611,510

A32150

Increase (decrease) in accounts payable

(13,862,850)

69,753,136

A32160

Increase (decrease) in accounts payable to related parties

(6,652,426)

783,829

A32180

Increase (decrease) in other payable

8,754,103

1,505,327

A32200

Increase (decrease) in provisions

(77,910)

(3,105,276)

A32230

Adjustments for increase (decrease) in other current liabilities

12,337,125

3,902,134

A32240

Increase (decrease) in net defined benefit liability

146,531

(223,004)

A32000

Total changes in operating liabilities

4,988,560

74,227,656

A30000

Total changes in operating assets and liabilities

123,332,322

50,558,368

A20000

Total adjustments

155,157,977

68,541,560

A33000

 Cash inflow (outflow) generated from operations

238,849,286

169,635,601

A33500

 Income taxes refund (paid)

(23,916,992)

(33,671,428)

AAAA

Net cash flows from (used in) operating activities

214,932,294

135,964,173

Cash flows from (used in) investing activities

B00010

 Acquisition of financial assets at fair value through other comprehensive income

(3,011,823)

(1,931,199)

B00020

 Proceeds from disposal of financial assets at fair value through other comprehensive income

3,206,871

864,354

B00040

 Acquisition of financial assets at amortised cost

(12,067,259)

(1,366,418)

B00060

 Proceeds from repayments of financial assets at amortised cost

1,279,800

1,369,020

B00100

 Acquisition of financial assets at fair value through profit or loss

(8,347,116)

(19,364,359)

B00200

 Proceeds from disposal of financial assets at fair value through profit or loss

2,493,641

12,590,164

B01800

 Acquisition of investments accounted for using equity method

(681,368)

(1,252,627)

B01900

 Proceeds from disposal of investments accounted for using equity method

496,722

0

B02200

 Net cash flow from acquisition of subsidiaries

(1,141,675)

(3,286,252)

B02700

 Acquisition of property, plant and equipment

(49,003,509)

(58,878,445)

B02800

 Proceeds from disposal of property, plant and equipment

2,534,904

2,122,108

B04400

 Decrease in other receivables due from related parties

16,025,396

27,157,760

B04500

 Acquisition of intangible assets

(671,586)

(49,624)

B05350

 Acquisition of use-of-right assets

(774,837)

(264,462)

B06800

 Decrease in other non-current assets

1,400,403

312,170

B07500

 Interest received

48,832,802

55,604,512

B07600

 Dividends received

8,511,162

10,291,713

B09900

 Other investing activities

348,479

0

BBBB

 Net cash flows from (used in) investing activities

9,431,007

23,918,415

Cash flows from (used in) financing activities

C00100

 Increase in short-term loans

54,507,172

0

C00200

 Decrease in short-term loans

0

(104,418,467)

C00500

 Increase in short-term notes and bills payable

22,811,117

14,498,375

C01200

 Proceeds from issuing bonds

21,050,000

31,060,000

C01300

 Repayments of bonds

(28,985,276)

(6,900,000)

C01600

 Proceeds from long-term debt

1,203,445

19,827,589

C01700

 Repayments of long-term debt

(5,208,949)

(948,194)

C04020

 Payments of lease liabilities

(6,330,697)

(3,650,739)

C04300

 Increase in other non-current liabilities

335,339

0

C04400

 Decrease in other non-current liabilities

0

(131,598)

C04500

 Cash dividends paid

(58,224,561)

(55,451,962)

C05600

 Interest paid

(46,257,075)

(50,971,434)

C05800

 Change in non-controlling interests

(1,987,711)

7,464,060

CCCC

 Net cash flows from (used in) financing activities

(47,087,196)

(149,622,370)

DDDD

Effect of exchange rate changes on cash and cash equivalents

(16,621,922)

(10,369,550)

EEEE

Net increase (decrease) in cash and cash equivalents

160,654,183

(109,332)

E00100

Cash and cash equivalents at beginning of period

857,864,362

788,662,325

E00200

Cash and cash equivalents at end of period

1,018,518,545

788,552,993

E00210

 Cash and cash equivalents reported in the statement of financial position

1,018,518,545

788,552,993

 

 

Unit: NT$ thousands

Statements of Change in Equity

 

3110

3100

3200

3310

3320

3350

3300

3410

3420

3400

3500

31XX

36XX

3XXX

Ordinary share

Total share capital

Capital surplus

Legal reserve

Special reserve

Unappropriated retained earnings (accumulated deficit)

Total retained earnings

Exchange differences on translation of foreign financial statements

Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income

Total other equity interest

Treasury shares

Total equity attributable to owners of parent

Non-controlling interests

Total equity

A1

 Equity at beginning of period

138,629,906

138,629,906

199,383,371

149,512,874

60,309,927

794,615,182

1,004,437,983

(113,889,466)

11,437,746

(102,451,720)

(15,194)

1,239,984,346

159,641,071

1,399,625,417

B1

Legal reserve appropriated

0

0

0

11,530,874

0

(11,530,874)

0

0

0

0

0

0

0

0

B3

Special reserve appropriated

0

0

0

0

42,141,793

(42,141,793)

0

0

0

0

0

0

0

0

B5

Cash dividends of ordinary share

0

0

0

0

0

(58,224,561)

(58,224,561)

0

0

0

0

(58,224,561)

0

(58,224,561)

C7

Changes in equity of associates and joint ventures accounted for using equity method

0

0

(500,891)

0

0

(6,557)

(6,557)

0

0

0

0

(507,448)

0

(507,448)

D1

 Profit (loss)

0

0

0

0

0

55,818,855

55,818,855

0

0

0

0

55,818,855

5,971,271

61,790,126

D3

 Other comprehensive income

0

0

0

0

0

0

0

(25,498,918)

(4,096,708)

(29,595,626)

0

(29,595,626)

(2,793,298)

(32,388,924)

D5

 Total comprehensive income

0

0

0

0

0

55,818,855

55,818,855

(25,498,918)

(4,096,708)

(29,595,626)

0

26,223,229

3,177,973

29,401,202

M7

 Changes in ownership interests in subsidiaries

0

0

3,408,846

0

0

0

0

0

0

0

0

3,408,846

0

3,408,846

O1

 Changes in non-controlling interests

0

0

0

0

0

0

0

0

0

0

0

0

(1,987,711)

(1,987,711)

Q1

 Disposal of investments in equity instruments designated at fair value through other comprehensive income

0

0

0

0

0

(4,170,365)

(4,170,365)

0

4,170,365

4,170,365

0

0

0

0

Y1

 Total increase (decrease) in equity

0

0

2,907,955

11,530,874

42,141,793

(60,255,295)

(6,582,628)

(25,498,918)

73,657

(25,425,261)

0

(29,099,934)

1,190,262

(27,909,672)

Z1

 Equity at end of period

138,629,906

138,629,906

202,291,326

161,043,748

102,451,720

734,359,887

997,855,355

(139,388,384)

11,511,403

(127,876,981)

(15,194)

1,210,884,412

160,831,333

1,371,715,745

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTFFDSUDESSEFF
Date   Source Headline
26th Apr 20247:00 amRNSSubsidiary obtaining Kai-Hong Energy shares
24th Apr 20248:38 amRNS113-2 Issue of Debt
11th Apr 202410:56 amRNSSubsidiary obtaining Jusda Supply Chain Shares
5th Apr 20248:45 amRNSUn-Audited Monthly Sales Ended March 31, 2024
3rd Apr 202411:23 amRNSSubsidiary obtaining FII AMC MEXICO Shares
3rd Apr 202411:23 amRNSThe earthquake has had a very slight impact
14th Mar 202410:28 amRNSFII Proposes distribution of profits
14th Mar 202410:27 amRNSFII announces 2022 Regular Shareholders' Meeting
14th Mar 202410:16 amRNSObtaining Shares
14th Mar 202410:14 amRNSIssue of Debt
14th Mar 202410:11 amRNSNotice of AGM
14th Mar 202410:09 amRNSDividend Declaration
14th Mar 202410:02 amRNS2023 Financial report has been approved by the BOD
13th Mar 20249:40 amRNSSubsidiary obtaining shares and Fund
12th Mar 202410:25 amRNSAnnouncement of obtaining PRC Investment
5th Mar 20241:38 pmRNSSubsidiary FII announces Dismissal of CFO
5th Mar 20248:00 amRNSUn-Audited Monthly Sales Ended February 29, 2024
4th Mar 20249:50 amRNSSubsidiary obtaining Land & Building & equipment
4th Mar 20248:18 amRNSInvestor Conference on FY23 4Q Financial Results
1st Mar 20241:31 pmRNSSubsidiary obtaining shares
29th Feb 202410:42 amRNSSubsidiary engaging others to build on owned land
27th Feb 202411:06 amRNSSubsidiary, FII AMC MEXICO obtaining land
7th Feb 20249:52 amRNSSubsidiary CNT Singapore obtaining shares
6th Feb 20249:26 amRNSFHH for engaging others to build on owned land
5th Feb 20247:50 amRNSUn-Audited Monthly Sales Ended January 31, 2024
31st Jan 202410:55 amRNSSubsidiary engaging others to build on rented land
31st Jan 202410:50 amRNSAppoint the functional committees member
17th Jan 20249:59 amRNSSubsidiary FHH India obtaining shares
15th Jan 20249:45 amRNSInvestment Private Equity Fund and Shares
10th Jan 20249:51 amRNS113-1 Issue of Debt
10th Jan 20249:45 amRNSSubsidiary obtaining shares
5th Jan 20247:56 amRNSUn-Audited Monthly Sales Ended December 31, 2023
3rd Jan 202410:02 amRNSResignation of the Company's independent director
29th Dec 202310:09 amRNSSubsidiary its distribution of dividends
28th Dec 202310:19 amRNSSubsidiary obtaining shares
28th Dec 202310:05 amRNSSubsidiary disposal & obtaining of equipment
27th Dec 202310:03 amRNSFoxconn Singapore Pte. Ltd. obtaining shares
19th Dec 20239:59 amRNSSubsidiary obtaining shares
14th Dec 202310:46 amRNSSupplementary Announcement of 2022/2/22
8th Dec 202310:11 amRNSSubsidiary obtaining shares
5th Dec 20239:44 amRNSBFIH obtaining Rising Stars Hi-Tech Shares
5th Dec 20238:05 amRNSUn-Audited Monthly Sales Ended November 30, 2023
1st Dec 20239:19 amRNSSubsidiary obtaining shares
27th Nov 202310:15 amRNSFHH for engaging others to build on owned land
27th Nov 202310:12 amRNSSubsidiary Foxconn SG obtaining FHH shares
21st Nov 20237:00 amRNS112-4 Issue of Debt
14th Nov 202310:19 amRNSFinancial report for FY 2023Q3
14th Nov 202310:15 amRNSObtaining subsidiary Shares
6th Nov 20237:00 amRNSUn-Audited Monthly Sales Ended October 31, 2023
3rd Nov 202310:01 amRNSFII hold 3rd Quarter of performance conference

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.